Anavex Life Sciences Corp. (AVXL) has a consensus analyst rating of Buy, based on 13 analysts covering the stock. Of those, 11 recommend buying, 2 recommend holding, and 0 recommend selling.
The analyst consensus price target for AVXL is $11.00, representing a +239.5% upside from the current price of $3.24. Price targets range from a low of $11.00 to a high of $11.00.
